Predictions
Inventiva SA
Start price
Target price
Perf. (%)
€6.02
27.10.22
27.10.22
-
27.10.23
27.10.23
-42.03%
28.10.23
28.10.23
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€8.01
05.09.22
05.09.22
-
05.10.26
05.10.26
-57.57%
11.03.24
11.03.24
Probably not worthwhile Investment
Abivax S.A.
Start price
Target price
Perf. (%)
€8.30
02.09.22
02.09.22
€5.00
31.12.24
31.12.24
85.30%
08.05.23
08.05.23
Could be very worthwhile Investment >20% year
Poxel S.A.
Start price
Target price
Perf. (%)
€2.49
20.08.22
20.08.22
-
20.08.23
20.08.23
-75.54%
07.06.23
07.06.23
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€10.23
09.08.22
09.08.22
€14.00
09.08.23
09.08.23
-46.91%
30.05.23
30.05.23
Small cyclical dependencies
Below average Marketposition
Few uniques
Cellectis Nom.
Start price
Target price
Perf. (%)
€3.52
07.08.22
07.08.22
€3.80
07.08.23
07.08.23
-52.13%
08.08.23
08.08.23
Could be worthwhile Investment >10% per year
Abivax S.A.
Start price
Target price
Perf. (%)
€9.10
04.08.22
04.08.22
-
04.08.23
04.08.23
81.32%
05.08.23
05.08.23
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€9.82
21.07.22
21.07.22
-
21.07.23
21.07.23
-30.16%
22.07.23
22.07.23
Revenue growth >5% per year expected
Could be very worthwhile Investment >20% year
High valuation
Growths slower than the competition
Valneva SE
Start price
Target price
Perf. (%)
€15.60
30.03.22
30.03.22
-
30.03.23
30.03.23
-55.74%
20.11.22
20.11.22
Could be worthwhile Investment >10% per year
Very valuable balance sheet
Innate Pharma
Start price
Target price
Perf. (%)
€2.51
07.03.22
07.03.22
-
07.03.23
07.03.23
21.39%
08.03.23
08.03.23
Probably not worthwhile Investment
Poxel S.A.
Start price
Target price
Perf. (%)
€3.04
20.02.22
20.02.22
€4.00
20.03.22
20.03.22
-11.39%
21.03.22
21.03.22
Could be worthwhile Investment >10% per year
Poxel S.A.
Start price
Target price
Perf. (%)
€4.07
15.02.22
15.02.22
€5.00
15.03.22
15.03.22
-25.36%
20.02.22
20.02.22
Could be worthwhile Investment >10% per year
Innate Pharma
Start price
Target price
Perf. (%)
€3.24
10.02.22
10.02.22
€3.80
10.02.23
10.02.23
-4.81%
11.02.23
11.02.23
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€15.03
05.02.22
05.02.22
€20.00
05.02.23
05.02.23
-57.41%
06.02.23
06.02.23
Revenue growth >5% per year expected
Differentiated customer and product portfolio
Good culture
Could be very worthwhile Investment >20% year
Innate Pharma
Start price
Target price
Perf. (%)
€3.51
01.02.22
01.02.22
€4.15
01.02.23
01.02.23
-7.69%
10.02.22
10.02.22
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€15.90
23.01.22
23.01.22
-
23.01.23
23.01.23
-5.47%
06.02.22
06.02.22
Could be very worthwhile Investment >20% year
Innate Pharma
Start price
Target price
Perf. (%)
€4.12
10.01.22
10.01.22
-
10.01.23
10.01.23
-14.85%
01.02.22
01.02.22
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€19.03
04.01.22
04.01.22
-
04.01.23
04.01.23
-7.46%
07.01.22
07.01.22
Risky Investment
Edap Tms S.A. ADR
Start price
Target price
Perf. (%)
€5.00
03.01.22
03.01.22
-
03.01.23
03.01.23
27.00%
15.05.22
15.05.22
Probably not worthwhile Investment
Quantum Genomics S.A.
Start price
Target price
Perf. (%)
€4.32
31.12.21
31.12.21
€5.00
31.12.22
31.12.22
-97.78%
01.01.23
01.01.23
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€24.64
16.12.21
16.12.21
€33.00
31.12.23
31.12.23
-67.02%
07.09.22
07.09.22
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€23.36
12.12.21
12.12.21
-
12.12.22
12.12.22
8.73%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€23.36
11.12.21
11.12.21
€30.00
11.12.22
11.12.22
8.73%
25.12.21
25.12.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business